EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Compound Heterozygous Variants in the Phospholipase Gene PNPLA6 Cause Hypopituitarism and Vision Loss

Sebastian Vishnopolska iD, James Liu iD, Maria Andrea Camilletti iD, Julian Martinez Mayer iD, Lucia Iglesias Garcia iD, Michelle Brinkmeier iD, Elisa Vaiani iD, Sofia Hebe Vidal iD, Marta Ciaccio iD, María Isabel Di Palma, Alicia Belgorosky iD, Marcelo Marti iD und 3 weitere

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/4515038 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Human Mutation, online erschienen am 19.06.2026. Verfasst von Sebastian Vishnopolska und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan, USA, umich.edu. Hauptthemen laut MEDLINE: Hypopituitarism, Heterozygote, Mutation, Phospholipases. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Agencia Nacional de Promoción Científica y Tecnológica, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PNPLA6 is a conserved lysophospholipase essential for maintaining nervous system integrity. Biallelic mutations in PNPLA6 have been identified in individuals with a broad spectrum of disorders that can include ataxia, vision loss, and pituitary hormone deficiency. Here, we report the identification of novel compound heterozygous variants in PNPLA6 (p.T1115P and p.Pro1142_Ala1143ins14) in a 10‐year‐old girl with combined pituitary hormone deficiency, including growth hormone, thyroid‐stimulating hormone, and gonadotropins. She also has vision loss and neurodevelopmental delay. Functional validation demonstrates that both variants, a missense substitution affecting a highly conserved residue within the catalytic domain and an intronic variant generating a novel splice acceptor site, completely abolish NTE activity, establishing their pathogenicity. Little is known about the cause of hypopituitarism in individuals with PNPLA6 deficiency. Here, we report the cell‐type‐specific expression of PNPLA6 in mouse pituitary development and in adult animals. PNPLA6 is expressed broadly in SOX2+ stem cells within the pituitary primordium as early as e10.5, prior to lineage specification, suggesting a role in progenitor maintenance and early differentiation. In neonates and adults, expression predominates in the cells that produce growth hormone and pro‐opiomelanocortin. These findings suggest that PNPLA6 could influence pituitary development at early stages, as well as contribute to the altered function of hormone‐secreting cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypopituitarismHeterozygoteMutationPhospholipasesLipaseHumansAcyltransferasesFemaleChildAnimalsMiceMutation, MissensePhenotype

Stichwörter der Autor:innen

Boucher–Neuhäuser syndromeGordon–Holmes syndromeLaurence–Moon syndromeOliver–McFarlane syndromegrowth hormone deficiencyneuropathy target esteraseretinitis pigmentosaspastic paraplegia type 39

Substanzen

PNPLA6 protein, humanAcyltransferasesPhospholipasesLipase

Autor:innen und Institutionen

  • Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan, USA, umich.edu.
  • Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, Maryland, USA, nih.gov.
  • Institute of Neurosciences (INEU-CONICET), Foundation for the Fight Against Neurological Diseases of Childhood (FLENI), Buenos Aires, Argentina.
  • Institute of Physiology, Molecular Biology and Neurosciences (IFIBYNE) CONICET, University of Buenos Aires, Buenos Aires, Argentina, uba.ar.
  • Endocrinology Service-CONICET, Garrahan Hospital, Buenos Aires, Argentina.
  • Ophthalmology Service, Garrahan Hospital, Buenos Aires, Argentina.

ORCID-Profile: Sebastian Vishnopolska, James Liu, Maria Andrea Camilletti, Julian Martinez Mayer, Lucia Iglesias Garcia, Michelle Brinkmeier, Elisa Vaiani, Sofia Hebe Vidal, Marta Ciaccio, Alicia Belgorosky, Marcelo Marti, Sally A Camper, Maria Ines Perez-Millan

Förderung

  • NICHD NIH HHS
  • Agencia Nacional de Promoción Científica y Tecnológica
  • National Institutes of Health

Zitieren

APA

Vishnopolska, S., Liu, J., Camilletti, M. A., Mayer, J. M., Garcia, L. I., Brinkmeier, M., Vaiani, E., Vidal, S. H., Ciaccio, M., Di Palma, M. I., Belgorosky, A., Marti, M., Hufnagel, R. B., Camper, S. A., & Perez-Millan, M. I. (2026). Compound Heterozygous Variants in the Phospholipase Gene PNPLA6 Cause Hypopituitarism and Vision Loss. Human Mutation, 2026(1). https://doi.org/10.1155/humu/4515038

Vancouver

Vishnopolska S, Liu J, Camilletti MA, Mayer JM, Garcia LI, Brinkmeier M, et al. Compound Heterozygous Variants in the Phospholipase Gene PNPLA6 Cause Hypopituitarism and Vision Loss. Human Mutation. 2026;2026(1). doi:10.1155/humu/4515038

BibTeX
@article{Vishnopolska2026,
  author = {Vishnopolska, Sebastian and Liu, James and Camilletti, Maria Andrea and Mayer, Julian Martinez and Garcia, Lucia Iglesias and Brinkmeier, Michelle and Vaiani, Elisa and Vidal, Sofia Hebe and Ciaccio, Marta and Di Palma, María Isabel and Belgorosky, Alicia and Marti, Marcelo and Hufnagel, Robert B and Camper, Sally A and Perez-Millan, Maria Ines},
  title = {Compound Heterozygous Variants in the Phospholipase Gene PNPLA6 Cause Hypopituitarism and Vision Loss},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/4515038}
}
Kostenlos starten →